Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?

Dengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100.303 persons by July 28, 2020, and expected to gr...

Full description

Bibliographic Details
Main Author: Gabriele Jessica Kembuan
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:IDCases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250920302353
_version_ 1819126794035396608
author Gabriele Jessica Kembuan
author_facet Gabriele Jessica Kembuan
author_sort Gabriele Jessica Kembuan
collection DOAJ
description Dengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100.303 persons by July 28, 2020, and expected to grow exponentially except if very strict measures were implemented. There are similar symptoms and laboratory findings with both dengue fever and COVID-19, paving way to dangerous possibilities such as incorrect or delayed initial treatment. This is especially worrisome in the context of the pandemic, where COVID-19 positive patients must be promptly identified, isolated and contact-traced, and eluded diagnosis might possibly endanger communities and healthcare workers.We present cases of patients who initially presented with symptoms and laboratory findings of dengue fever, including positive NS1 and/or IgM serology results. During the course of illness these patients fail to show characteristic dengue symptoms, and two cases begin to show respiratory symptoms. Upon further investigation with chest X-ray or contact tracing, the patients were indicated for COVID-19 swab test, which yielded positive results. Repeat dengue IgM/IgG returned positive in one case, suggesting dengue coinfection; however in all other cases, the repeat testing returned negative, suggesting that the initial serologies were false positives. These cases highlight the importance of comprehensively studying patients with apparent dengue fever symptoms and serology, and using the appropriate adjuvant test according to the course of the disease, since a serological overlap may exist between the two diseases.
first_indexed 2024-12-22T08:01:41Z
format Article
id doaj.art-e695e2d20aed4cd9ba50e0d3f93f7c77
institution Directory Open Access Journal
issn 2214-2509
language English
last_indexed 2024-12-22T08:01:41Z
publishDate 2020-01-01
publisher Elsevier
record_format Article
series IDCases
spelling doaj.art-e695e2d20aed4cd9ba50e0d3f93f7c772022-12-21T18:33:15ZengElsevierIDCases2214-25092020-01-0122e00927Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?Gabriele Jessica Kembuan0Faculty of Medicine, Hasanuddin University, IndonesiaDengue fever is an extremely common infection in Indonesia, with an estimated 77.96 cases / 100.000 person-years in 2016. However, in 2020 the threat of extremely contagious SARS CoV-2 or COVID-19 in Indonesia emerged, which has infected more than 100.303 persons by July 28, 2020, and expected to grow exponentially except if very strict measures were implemented. There are similar symptoms and laboratory findings with both dengue fever and COVID-19, paving way to dangerous possibilities such as incorrect or delayed initial treatment. This is especially worrisome in the context of the pandemic, where COVID-19 positive patients must be promptly identified, isolated and contact-traced, and eluded diagnosis might possibly endanger communities and healthcare workers.We present cases of patients who initially presented with symptoms and laboratory findings of dengue fever, including positive NS1 and/or IgM serology results. During the course of illness these patients fail to show characteristic dengue symptoms, and two cases begin to show respiratory symptoms. Upon further investigation with chest X-ray or contact tracing, the patients were indicated for COVID-19 swab test, which yielded positive results. Repeat dengue IgM/IgG returned positive in one case, suggesting dengue coinfection; however in all other cases, the repeat testing returned negative, suggesting that the initial serologies were false positives. These cases highlight the importance of comprehensively studying patients with apparent dengue fever symptoms and serology, and using the appropriate adjuvant test according to the course of the disease, since a serological overlap may exist between the two diseases.http://www.sciencedirect.com/science/article/pii/S2214250920302353COVID-19Dengue feverSerologyCase series
spellingShingle Gabriele Jessica Kembuan
Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?
IDCases
COVID-19
Dengue fever
Serology
Case series
title Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?
title_full Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?
title_fullStr Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?
title_full_unstemmed Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?
title_short Dengue serology in Indonesian COVID-19 patients: Coinfection or serological overlap?
title_sort dengue serology in indonesian covid 19 patients coinfection or serological overlap
topic COVID-19
Dengue fever
Serology
Case series
url http://www.sciencedirect.com/science/article/pii/S2214250920302353
work_keys_str_mv AT gabrielejessicakembuan dengueserologyinindonesiancovid19patientscoinfectionorserologicaloverlap